Artificial intelligence is reshaping how clinicians identify women at higher risk of breast cancer – and may soon guide decisions on supplemental screening and treatment. At the European Society of Breast Imaging (EUSOBI) annual scientific meeting in Aberdeen, Scotland, two experts presented their latest findings on AI-driven risk stratification and response prediction.
A first-of-its-kind study could lead to quicker and more targeted support for vulvodynia - a painful chronic condition estimated to affect more than one in 10 women with no known cause.
Pacemakers have a range of different functions, not all of which are needed for every patient – switching off unnecessary features could help extend the battery life of the devices by several years.
Not all PCOS is the same: Researchers identified four subgroups with distinct symptoms and different responses to treatment – opening the door to precision medicine for millions of women worldwide.
Biomarker testing is ushering in a novel era of therapy personalisation for gastroesophageal and colorectal cancers, according to experts presenting at the 37th European Congress of Pathology in Vienna this September. During a session on state-of-the-art in gastrointestinal biomarkers, speakers outlined how targeted therapies and immunotherapies are transforming treatment options – but…
A new type of SPECT imaging provides strong prognostic information to guide prostate cancer treatments according to tumor evolution, significantly impacting patients' overall survival.
An expert summit for craniomaxillofacial (CMF) care brought together leading surgeons to explore how digital technologies are reshaping surgical planning, precision, and patient outcomes.
Stroke patients in four NHS hospitals are now receiving genetic tests that determine whether a commonly prescribed drug will work for them – a breakthrough that could transform treatment for millions. Digital approaches are spearheading a drive to help make genomic medicine part of everyday care. The role of digital tools was a central theme at the HETT (Healthcare Excellence Through…
A novel procedure at UC San Diego Health uses a combination of artificial intelligence and 3D printing to develop a customized implant for the spine during fusion surgery.
A new study shows that a gene expression test on routinely collected prostate tissue can help guide therapy choices for prostate cancer patients whose cancer has spread to other parts of the body.
A newly developed method to accurately quantify how much radiation is absorbed by the blood during cancer treatment could lead to more personalised, preventive, and safer radiotherapy.
A treatment commonly used for obstructive sleep apnoea (OSA), lowers the risk of serious cardiovascular events in some patients but not others, according to new research.
Molecular profiling of over 1,000 nasopharyngeal cancer (NPC) tumours reveals distinct differences in tumour microenvironment of locoregionally advanced NPC, supporting personalised treatment.
From personalized medical guides and implants to advanced surgical planning solutions: 3D printing and visualization has seen considerable growth over the past years and is already making a significant impact in healthcare. AI, cloud, and virtual/augmented reality technologies show promise to further advance the number of applications.
The new national Precision Omics Initiative Sweden (PROMISE) aims to generate and integrate extensive molecular data to create a model for precision medicine implementation for Sweden.
The boom in interventional radiology procedures has enabled great strides in ischemic stroke management. But while a myriad of techniques are available, the challenge remains in choosing the most appropriate thrombectomy treatment on the spot, according to Jordi Blasco Andaluz, a neuroradiologist at Hospital Clinic Barcelona. The new ROSSETTI registry is designed to change this.
Certain gene alterations can serve as a prognostic and predictive biomarker for prostate cancer. Now, researchers confirm the feasibility of using NGS on this marker for precise patient stratification and treatment selection.
Researchers developed a smart patch capable of real-time biometric signal monitoring and drug delivery. Potential applications include glucose management, pain relief, and chronic disease treatment.
A new personalised oncology platform has been tested to detect circulating tumour DNA (ctDNA) in patients with lung adenocarcinoma before surgery, to predict their risk of cancer relapse.
